Blog

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

March 31, 2026

Ajmeeta Sangtani

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

Kyfora Bio today announced the launch of SmashGene™, a next‑generation transfection reagent engineered to deliver higher titers on its own compared to leading competitor reagents that require enhancers. Designed to simplify workflows while maximizing performance, SmashGene™ enables process developers to achieve more with less complexity, fewer components, and lower overall cost.

All AAV Manufacturing Approved Therapies Cell and Gene Therapies Cell and Gene Therapy Products FDA Approved Cell and Gene Therapy Products Next-Gen Bioprocessing PEI Transfection Press Release Transfection Protocol Upstream

Press Release

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

Ajmeeta Sangtani

March 31, 2026

Kyfora Bio today announced the launch of SmashGene™, a next‑generation transfection reagent engineered to deliver higher titers on its own compared...

Approved Therapies

Approved Cell and Gene Therapies: Regulatory Strategy Across the US and EU

Ajmeeta Sangtani

March 02, 2026

In this blog, we break down the key differences in the regulatory approval processes for cell and gene therapies between the US and EU, offer insig...

AAV Manufacturing

Navigating Upstream AAV Manufacturing Process Challenges in Next-Gen Bioprocessing

Ajmeeta Sangtani

February 16, 2026

Adeno-associated virus (AAV) vectors have become the dominant delivery platform for gene therapies, with several FDA-approved products and many mor...

PEI Transfection

Polyethylenimine (PEI) Transfection Protocol Optimization: Dos and Don’ts for High Efficiency

Ajmeeta Sangtani

December 16, 2025

Efficient gene delivery is essential for advancing cell and gene therapies. Polyethylenimine (PEI) transfection has become a widely adopted method ...

Blog

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

Filter by Category

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

Approved Cell and Gene Therapies: Regulatory Strategy Across the US and EU

Navigating Upstream AAV Manufacturing Process Challenges in Next-Gen Bioprocessing

Polyethylenimine (PEI) Transfection Protocol Optimization: Dos and Don’ts for High Efficiency

Newsletter

Blog

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

Follow us

Filter by Category

SmashGene™ Sets a New Standard in Transfection: Higher Titers Without the Complexity or Cost of Competitor Reagents.

Approved Cell and Gene Therapies: Regulatory Strategy Across the US and EU

Navigating Upstream AAV Manufacturing Process Challenges in Next-Gen Bioprocessing

Polyethylenimine (PEI) Transfection Protocol Optimization: Dos and Don’ts for High Efficiency

Newsletter